Cargando…

Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease

Parasitic helminths and their isolated secreted products show promise as novel treatments for allergic and autoimmune conditions in humans. Foremost amongst the secreted products is ES-62, a glycoprotein derived from Acanthocheilonema viteae, a filarial nematode parasite of gerbils, which is anti-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doonan, James, Thomas, David, Wong, Michelle H., Ramage, Hazel J., Al-Riyami, Lamyaa, Lumb, Felicity E., Bell, Kara S., Fairlie-Clarke, Karen J., Suckling, Colin J., Michelsen, Kathrin S., Jiang, Hui-Rong, Cooke, Anne, Harnett, Margaret M., Harnett, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222842/ https://www.ncbi.nlm.nih.gov/pubmed/30336585 http://dx.doi.org/10.3390/molecules23102669

Ejemplares similares

Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62
por: Lumb, Felicity E., et al.
Publicado: (2017)

The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis
por: Doonan, James, et al.
Publicado: (2019)

Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts
por: Corbet, Marlene, et al.
Publicado: (2021)

The role of individual protein kinase C isoforms in mouse mast cell function and their targeting by the immunomodulatory parasitic worm product, ES-62
por: Bell, Kara S., et al.
Publicado: (2015)

Protection Against Arthritis by the Parasitic Worm Product ES-62, and Its Drug-Like Small Molecule Analogues, Is Associated With Inhibition of Osteoclastogenesis
por: Doonan, James, et al.
Publicado: (2018)

The parasitic worm product ES-62 protects the osteoimmunology axis in a mouse model of obesity-accelerated ageing
por: Harnett, Margaret M., et al.
Publicado: (2022)

IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62
por: Ball, Dimity H., et al.
Publicado: (2018)

The Parasitic Worm Product ES-62 Targets Myeloid Differentiation Factor 88–Dependent Effector Mechanisms to Suppress Antinuclear Antibody Production and Proteinuria in MRL/lpr Mice
por: Rodgers, David T, et al.
Publicado: (2015)

Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents Development of Collagen-Induced Arthritis
por: Al-Riyami, Lamyaa, et al.
Publicado: (2013)

Site-specific glycoproteomic characterization of ES-62: The major secreted product of the parasitic worm Acanthocheilonema viteae
por: North, Simon J, et al.
Publicado: (2019)

Small Molecule Analogues of the parasitic worm product ES-62 interact with the TIR domain of MyD88 to inhibit pro-inflammatory signalling
por: Suckling, Colin J., et al.
Publicado: (2018)

The parasitic worm-derived immunomodulator, ES-62 and its drug-like small molecule analogues exhibit therapeutic potential in a model of chronic asthma
por: Coltherd, J. C., et al.
Publicado: (2016)

Protective effect of small molecule analogues of the Acanthocheilonema viteae secreted product ES-62 on oxazolone-induced ear inflammation
por: Al-Riyami, Lamyaa, et al.
Publicado: (2015)

Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus
por: Rodgers, D T, et al.
Publicado: (2015)

Development of Acanthocheilonema viteae in Meriones shawi: Absence of microfilariae and production of active ES‐62
por: Lumb, Felicity E., et al.
Publicado: (2020)

The parasitic worm product ES-62 promotes health- and life-span in a high calorie diet-accelerated mouse model of ageing
por: Crowe, Jenny, et al.
Publicado: (2020)

Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints
por: Rodgers, David T, et al.
Publicado: (2014)

Testing small molecule analogues of the Acanthocheilonema viteae immunomodulator ES‐62 against clinically relevant allergens
por: Janicova, L., et al.
Publicado: (2016)

Mast Cell Subsets and Their Functional Modulation by the Acanthocheilonema viteae Product ES-62
por: Ball, Dimity H., et al.
Publicado: (2013)

ES‐62 Protects Against Collagen‐Induced Arthritis by Resetting Interleukin‐22 Toward Resolution of Inflammation in the Joints
por: Pineda, Miguel A., et al.
Publicado: (2014)

The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation
por: Ahmed, Umul Kulthum, et al.
Publicado: (2016)

Small molecule analogues of the immunomodulatory parasitic helminth product ES-62 have anti-allergy properties
por: Rzepecka, Justyna, et al.
Publicado: (2014)

The helminth product, ES-62 modulates dendritic cell responses by inducing the selective autophagolysosomal degradation of TLR-transducers, as exemplified by PKCδ
por: Eason, Russell J., et al.
Publicado: (2016)

The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype
por: Rzepecka, Justyna, et al.
Publicado: (2013)

Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome
por: Rzepecka, Justyna, et al.
Publicado: (2015)

Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis
por: Pineda, M A, et al.
Publicado: (2014)

A novel therapeutic approach to cytokine modulation in articular inflammation using filarial nematode derived ES-62
por: McInnes, IB, et al.
Publicado: (2003)

Parasitic worms and inflammatory diseases
por: ZACCONE, P, et al.
Publicado: (2006)

Viewpoints on Acid-Induced Inflammatory Mediators in Esophageal Mucosa
por: Harnett, Karen M, et al.
Publicado: (2010)

Brugia malayi Antigen (BmA) Inhibits HIV-1 Trans-Infection but Neither BmA nor ES-62 Alter HIV-1 Infectivity of DC Induced CD4(+) Th-Cells
por: Mouser, Emily E. I. M., et al.
Publicado: (2016)

Machine development SE 62 integer resonance with ES 43
por: Bleeker, J, et al.
Publicado: (1971)

Apicomplexan autophagy and modulation of autophagy in parasite-infected host cells
por: Latré de Laté, Perle, et al.
Publicado: (2017)

Temperate Propolis Has Anti-Inflammatory Effects and Is a Potent Inhibitor of Nitric Oxide Formation in Macrophages
por: Alanazi, Samyah, et al.
Publicado: (2020)

Worms and the Treatment of Inflammatory Bowel Disease: Are Molecules the Answer?
por: Ruyssers, Nathalie E., et al.
Publicado: (2008)

Inflammatory Conditions Due to Calcified Remains of Guinea Worms
por: Connor, F. Powell
Publicado: (1918)

Helminth Therapy: Advances in the use of Parasitic Worms Against Inflammatory Bowel Diseases and its Challenges
por: Maruszewska-Cheruiyot, M., et al.
Publicado: (2018)

Allergy and Parasites
por: Bruschi, Fabrizio, et al.
Publicado: (2013)

Vaccination against the brown stomach worm, Teladorsagia circumcincta, followed by parasite challenge, induces inconsistent modifications in gut microbiota composition of lambs
por: Rooney, James, et al.
Publicado: (2021)

Correspondence
por: Harnett, J. M.
Publicado: (1868)

Worms, flies and four-legged friends: the applicability of biological models to the understanding of intestinal inflammatory diseases
por: Lin, Joyce, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_so2sghrftimbfo6i7gdfi44fbe